Evidence map›Paper›PMID 25746798›Full record

ArticleThe Journal of molecular diagnostics : JMD2015

Technical reproducibility of single-nucleotide and size-based DNA biomarker assessment using DNA extracted from formalin-fixed, paraffin-embedded tissues.

Shenli Zhang, Iain B Tan, Nur S Sapari, Heike I Grabsch, Alicia Okines, Elizabeth C Smyth, Toru Aoyama, Lindsay C Hewitt, Imran Inam, Dan Bottomley and 8 more

Open access · bronzeAbstract readEvaluation Study
In one paragraph

Article in The Journal of molecular diagnostics : JMD, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 11 institutions in 3 countries.

Shenli ZhangCancer and Stem Cell Biology Program, Duke-NUS Graduate Medical School, Singapore, Singapore.
Iain B TanDepartment of Medical Oncology, National Cancer Centre, Singapore, Singapore.
Nur S SapariCancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
Heike I GrabschLeeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom.
Alicia OkinesDepartment of Gastrointestinal Oncology, Royal Marsden Hospital, Sutton, United Kingdom.
Elizabeth C SmythDepartment of Gastrointestinal Oncology, Royal Marsden Hospital, Sutton, United Kingdom.
Toru AoyamaDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Lindsay C HewittLeeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom.
Imran InamLeeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom.
Dan BottomleyLeeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom.
Matthew NankivellMedical Research Council Clinical Trials Unit, University College London, London, United Kingdom.
Sally P StenningMedical Research Council Clinical Trials Unit, University College London, London, United Kingdom.
David CunninghamDepartment of Gastrointestinal Oncology, Royal Marsden Hospital, Sutton, United Kingdom.
Andrew WotherspoonDepartment of Pathology, Royal Marsden Hospital, Sutton, United Kingdom.
Akira TsuburayaGastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan.
Takaki YoshikawaDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Richie SoongCancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore; Department of Pathology, National University Health System, Singapore, Singapore.
Patrick TanCancer and Stem Cell Biology Program, Duke-NUS Graduate Medical School, Singapore, Singapore; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore; Department of Cellular and Molecular Research, National Cancer Centre, Singapore, Singapore; Cancer Therapeutics and Stratified Oncology Group, Genome Institute of Singapore, Singapore, Singapore. Electronic address: gmstanp@duke-nus.edu.sg.
Royal Marsden Hospital · GBUniversity of Leeds · GBNational University of Singapore · SGDuke-NUS Medical School · SGKanagawa Cancer CenterKanagawa Prefectural Hospital Organization · JPMedical Research Council · GBNational Cancer Centre Singapore · SGNational University Cancer Institute, Singapore · SGUniversity College London · GBYokohama City University · JP

Funding

Cancer Research UK C20023/A7217Cancer Research UK C26441/A8944Medical Research Council MC_U122861327Medical Research Council MC_UU_12023/20Medical Research Council MC_UU_12023/28Medical Research Council MC_UU_12023/3
6 · The paper itself

Abstract

DNA extracted from formalin-fixed, paraffin-embedded (FFPE) tissues has been used in the past to analyze genetic polymorphisms. We evaluated the technical reproducibility of different types of assays for gene polymorphisms using DNA extracted from FFPE material. By using the MassARRAY iPLEX system, we investigated polymorphisms in DPYD (rs1801159 and rs3918290), UMPS (rs1801019), ERCC1 (rs11615), ERCC1 (rs3212986), and ERCC2 (rs13181) in 56 FFPE DNA samples. By using PCR, followed by size-based gel electrophoresis, we also examined TYMS 5' untranslated region 2R/3R repeats and GSTT1 deletions in 50 FFPE DNA samples and 34 DNAs extracted from fresh-frozen tissues and cell lines. Each polymorphism was analyzed by two independent runs. We found that iPLEX biomarker assays measuring single-nucleotide polymorphisms provided consistent concordant results. However, by using FFPE DNA, size-based PCR biomarkers (GSTT1 and TYMS 5' untranslated region) were discrepant in 32.7% (16/49, with exact 95% CI, 19.9%-47.5%; exact binomial confidence limit test) and 4.2% (2/48, with exact 95% CI, 0.5%-14.3%) of cases, respectively, whereas no discrepancies were observed using intact genomic DNA. Our findings suggest that DNA from FFPE material can be used to reliably test single-nucleotide polymorphisms. However, results based on size-based PCR biomarkers, and particularly GSTT1 deletions, using FFPE DNA need to be interpreted with caution. Independent repeated assays should be performed on all cases to assess potential discrepancies.

Indexed as

Paraffin EmbeddingPolymorphism, Single NucleotideTissue FixationCell LineDNAFormaldehydeGene DosageGenetic MarkersGenotyping TechniquesHumansOligonucleotide Array Sequence AnalysisParaffinPolymerase Chain ReactionReproducibility of ResultsDNAFormaldehydeGenetic MarkersParaffin

Identifiers

PMID25746798
PMCPMC4411247
OpenAlexW2124892502

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.